Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation.
OBJECTIVE
To show, using a model study, how electronic structure theory can be applied in combination with LC/UV/MS/MS for the prediction and identification of oxidative degradants.


METHODS
The benzyloxazole 1, was used to represent an active pharmaceutical ingredient for oxidative forced degradation studies. Bond dissociation energies (BDEs) calculated at the B3LYP/6-311+G(d,p)//B3LYP/6-31G(d) level with isodesmic corrections were used to predict sites of autoxidation. In addition, frontier molecular orbital (FMO) theory at the Hartree-Fock level was used to predict sites of peroxide oxidation and electron transfer. Compound 1 was then subjected to autoxidation and H2O2 forced degradation as well as formal stability conditions. Samples were analyzed by LC/UV/MS/MS and degradation products proposed.


RESULTS
The computational BDEs and FMO analysis of 1 was consistent with the LC/UV/MS/MS data and allowed for structural proposals, which were confirmed by LC/MS/NMR. The autoxidation conditions yielded a number of degradants not observed under peroxide degradation while formal stability conditions gave both peroxide and autoxidation degradants.


CONCLUSIONS
Electronic structure methods were successfully applied in combination with LC/UV/MS/MS to predict degradation pathways and assist in spectral identification. The degradation and excipient stability studies highlight the importance of including both peroxide and autoxidation conditions in forced degradation studies.
Reid
Darren L
DL
Analytical Research and Development, Pharmaceutical Sciences, Pfizer Global Research and Development, Ann Arbor, Michigan 48105, USA.
Calvitt
C Jeffrey
CJ
Zell
Mark T
MT
Miller
Kenneth G
KG
Kingsmill
Carol A
CA
D002851:Chromatography, High Pressure Liquid; D003198:Computer Simulation; D004355:Drug Stability; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D008956:Models, Chemical; D008958:Models, Molecular; D008968:Molecular Conformation; D010080:Oxazoles / Q000737:chemistry; D010084:Oxidation-Reduction; D010666:Phenylpropionates / Q000737:chemistry; D013816:Thermodynamics
C499113:3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-pyrrol-1-ylpropionic acid; D010080:Oxazoles; D010666:Phenylpropionates